¡Ya estamos en ! Descubre más
CEMI

Chembio diagnostics, Inc.

Excluida de cotización

CEMI dejó de cotizar en bolsa el 27 de abril de 2023.

 

Acerca de: Chembio Diagnostics Inc is a company that develops, manufactures, and commercializes point-of-care diagnostic tests that detect infectious diseases. The products of the company include rapid tests for the detection of HIV 1/2 antibodies and a multiplex rapid test for the detection of HIV and syphilis antibodies. The company offered rapid medical tests that are offered in Africa, Asia, Europe, and the Middle East, Latin America and the United States, of which key revenue is derived from Latin America.

Empleados: 188

Noticias

Positivo
Neutral
Negativo
Sentimiento 3 meses
Positivo 0%
Neutral 0%
Negativo 0%

No hemos recibido artículos de noticias recientes sobre CEMI.

Gráficos de precios implementados con Lightweight Charts™